Impact of a non-medical switch from tocilizumab to upadacitinib in a cohort of patients with rheumatoid arthritis in routine clinical practice

被引：0
|
作者：
White, Douglas [1 ]
Poppelwell, David [2 ]
机构：
[1] Te Whatu Ora Waikato, Waikato Hosp, Rheumatol Clin, Hamilton, New Zealand
[2] AbbVie Ltd, Med Affairs, Auckland, New Zealand
来源：
NEW ZEALAND MEDICAL JOURNAL | 2023年 / 136卷 / 1581期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：74 / 78
页数：5
相关论文
共 50 条
  • [31] Comment on: Tocilizumab induces corticosteroid sparing in rheumatoid arthritis patients in clinical practice: reply
    Fortunet, Clementine
    Maillefert, Jean Francis
    RHEUMATOLOGY, 2015, 54 (04) : 751 - 752
  • [32] LONG-TERM TOCILIZUMAB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS IN DAILY CLINICAL PRACTICE
    Ono, Y.
    Hirano, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1296 - 1296
  • [33] TOCILIZUMAB IN THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS IN REAL CLINICAL PRACTICE: RESULTS OF TRUST STUDY
    Gerli, R.
    Afeltra, A.
    Bagnato, G.
    Carlino, G.
    Foti, R.
    Mazzone, A.
    Minisola, G.
    Pappone, N.
    Russo, R.
    Semeraro, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 682 - 683
  • [34] Costs Associated with Non-Medical Switching from Originator to Biosimilar Etanercept in Patients with Rheumatoid Arthritis in the UK
    Onishchenko, Kateryna
    Alexopoulos, Stamatia Theodora
    Curiale, Cinzia
    Tarallo, Miriam
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [35] Suppression of joint destruction with subcutaneous tocilizumab for Japanese patients with rheumatoid arthritis in clinical practice
    Nakashima, Yasuharu
    Kondo, Masakazu
    Shono, Eisuke
    Ishinishi, Takashi
    Tsukamoto, Hiroshi
    Kuroda, Koji
    Maeyama, Akira
    Harada, Hiroshi
    Maekawa, Masayuki
    Shimauchi, Takashi
    Nagamine, Ryuji
    Jojima, Hiroshi
    Yoshizawa, Seiji
    Tsuru, Tomomi
    Otsuka, Takeshi
    Miyahara, Hisaaki
    Suematsu, Eiichi
    Wada, Ken
    Yoshizawa, Shigeru
    Inoue, Yasushi
    Fukuda, Takaaki
    Ikemura, Satoshi
    Haraguchi, Akihisa
    MODERN RHEUMATOLOGY, 2020, 30 (05) : 807 - 815
  • [36] Costs associated with non-medical switching from originator to biosimilar etanercept in patients with rheumatoid arthritis in the UK
    Tarallo, Miriam
    Onishchenko, Kateryna
    Alexopoulos, Stamatia T.
    JOURNAL OF MEDICAL ECONOMICS, 2019, 22 (11) : 1162 - 1170
  • [37] EFFICACY AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CLINICAL PRACTICE: TWO YEARS' EXPERIENCE
    Quesada-Masachs, Estefania
    Carolina Diaz, Ana
    Avila, Gabriela
    Acosta, Isabel
    Sans, Xavier
    Alegre, Cayetano
    Marsal, Sara
    RHEUMATOLOGY, 2012, 51 : 137 - 137
  • [38] Erratum to: Are the Goals of Therapy Achievable in Patients with Rheumatoid Arthritis Receiving Upadacitinib in Real Clinical Practice?
    V. N. Amirdzhanova
    A. E. Karateev
    E. Yu. Pogozheva
    E. S. Filatova
    R. R. Samigullina
    V. I. Mazurov
    O. N. Anoshenkova
    N. A. Lapkina
    A. A. Baranov
    T. Yu. Grineva
    A. M. Lila
    E. L. Nasonov
    Doklady Biochemistry and Biophysics, 2023, 513 (1) : 363 - 363
  • [39] A Nationwide Non-Medical Switch from Originator to Biosimilar Infliximab in Patients with Inflammatory Arthritis. Eleven Months' Clinical Outcomes from the Danbio Registry
    Glintborg, Bente
    Sorensen, Inge Juul
    Jensen, Dorte Vendelbo
    Krogh, Niels Steen
    Loft, Anne Gitte
    Espesen, Jakob
    Olsen, Jimmi
    Hendricks, Oliver
    Grydehoj, Jolanta
    Hansen, Inger Marie Jensen
    Sorensen, Michael Veedfald
    Chrysidis, Stavros
    Andersen, Birgitte Lange
    Manilo, Natalia
    Klarlund, Mette
    Andersen, Lis Smedegaard
    Nordin, Henrik
    Kristensen, Salome
    Norregaard, Jesper
    Hetland, Merete Lund
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [40] Multimorbidity in rheumatoid arthritis: common mechanistic links and impact and challenges in routine clinical practice
    Surandran, Sanggeeta
    Ahmed, Saad
    Walton, Tom
    Nikiphorou, Elena
    Dey, Mrinalini
    RHEUMATOLOGY, 2023, 62 (SI3) : SI260 - SI270
12345